When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AVRO - Avrobio launches mid-stage AVR-RD-04 trial for Cystinosis
AVROBIO Inc.
The first patient has been dosed in AVROBIO's (NASDAQ:AVRO) Phase 1/2 clinical trial of AVR-RD-04 investigational gene therapy program for cystinosis, a devastating lysosomal storage disease.
More news on: AVROBIO, Inc., Healthcare stocks news,